Patient info Open main menu

Rivaroxaban Accord 10 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg
Contains active substance:
Similar medicines:

Patient leaflet - Rivaroxaban Accord 10 mg film-coated tablets

1. What Rivaroxaban Accord is and what it is used for

Rivaroxaban Accord contains the active substance rivaroxaban and is used in adults to

  • prevent blood clots in the veins after a hip or knee replacement operation. Your doctor has prescribed this medicine for you because after an operation you are at an increased risk of getting blood clots.
  • treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from re-occurring in the blood vessels of your legs and/or lungs.

Rivaroxaban Accord belongs to a group of medicines called antithrombotic agents. It works by blocking a blood clotting factor (factor Xa) and thus reducing the tendency of the blood to form clots.

2. What you need to know before you take Rivaroxaban Accord

Do not take Rivaroxaban Accord

  • if you are allergic to rivaroxaban or any of the other ingredients of this medicine (listed in section 6)
  • if you are bleeding excessively
  • if you have a disease or condition in an organ of the body that increases the risk of serious bleeding (e.g., stomach ulcer, injury or bleeding in the brain, recent surgery of the brain or eyes)
  • if you are taking medicines to prevent blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open
  • if you have a liver disease which leads to an increased risk of bleeding
  • if you are pregnant or breast-feeding

Do not take Rivaroxaban Accord and tell your doctor if any of these apply to you.

Warnings and precautions

Talk to your doctor or pharmacist before taking Rivaroxaban Accord.

Take special care with Rivaroxaban Accord

  • if you have an increased risk of bleeding, as could be the case in situations such as:

    • moderate or severe kidney disease, since your kidney function may affect the amount of medicine that works in your body
    • if you are taking other medicines to prevent blood clotting (e.g. warfarin, dabigatran, apixaban or heparin), when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open (see section ‘Other medicines and Rivaroxaban Accord’)
    • bleeding disorders
    • very high blood pressure, not controlled by medical treatment
    • diseases of your stomach or bowel that might result in bleeding, e.g. inflammation of the bowels or stomach, or inflammation of the oesophagus (gullet), e.g. due to gastroesophageal reflux disease (disease where stomach acid goes upwards into the oesophagus) or tumours located in the stomach or bowels or genital tract or urinary tract
    • a problem with the blood vessels in the back of your eyes (retinopathy)
    • a lung disease where your bronchi are widened and filled with pus (bronchiectasis), or previous bleeding from your lung
  • if you have a prosthetic heart valve
  • if your doctor determines that your blood pressure is unstable or another treatment or surgical procedure to remove the blood clot from your lungs is planned.
  • if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.

If any of the above apply to you, tell your doctor before you take Rivaroxaban Accord. Your doctor will decide, if you should be treated with this medicine and if you should be kept under closer observation.

If you need to have an operation

  • it is very important to take Rivaroxaban Accord before and after the operation exactly at the times you have been told by your doctor.
  • If your operation involves a catheter or injection into your spinal column (e.g. for epidural or spinal anaesthesia or pain reduction):

    • it is very important to take Rivaroxaban Accord exactly at the times you have been told by your doctor
    • tell your doctor immediately if you get numbness or weakness of your legs or problems with your bowel or bladder after the end of anaesthesia, because urgent care is necessary.

Children and adolescents

Rivaroxaban Accord is not recommended for people under 18 years of age. There is not enough information on its use in children and adolescents.

Other medicines and Rivaroxaban Accord

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. If you are taking

  • some medicines for fungal infections (e.g. fluconazole, itraconazole, voriconazole, posaconazole), unless they are only applied to the skin
  • ketoconazole tablets (used to treat Cushing’s syndrome

    • when the body produces an excess of cortisol)
  • some medicines for bacterial infections (e.g. clarithromycin, erythromycin)
  • some anti-viral medicines for HIV / AIDS (e.g. ritonavir)
  • other medicines to reduce blood clotting (e.g. enoxaparin, clopidogrel or vitamin K antagonists such as warfarin and acenocoumarol)
  • anti-inflammatory and pain relieving medicines (e.g. naproxen or acetylsalicylic acid)
  • dronedarone, a medicine to treat abnormal heart beat
  • some medicines to treat depression (selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs)).

If any of the above apply to you, tell your doctor before taking Rivaroxaban Accord, because the effect of Rivaroxaban Accord may be increased. Your doctor will decide, if you should be treated with this medicine and if you should be kept under closer observation. If your doctor thinks that you are at increased risk of developing stomach or bowel ulcers, he may also use a preventative ulcer treatment.

If you are taking:

  • some medicines for treatment of epilepsy (phenytoin, carbamazepine, phenobarbital)
  • St John’s Wort (Hypericum perforatum), a herbal product used for depression
  • rifampicin, an antibiotic

If any of the above apply to you, tell your doctor before taking Rivaroxaban Accord, because the effect of Rivaroxaban Accord may be reduced. Your doctor will decide, if you should be treated with Rivaroxaban Accord and if you should be kept under closer observation.

Pregnancy and breast-feeding

Do not take Rivaroxaban Accord if you are pregnant or breast feeding. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking Rivaroxaban Accord. If you become pregnant while you are taking this medicine, tell your doctor immediately, who will decide how you should be treated.

Driving and using machines

Rivaroxaban Accord may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, ‘Possible side effects’). You should not drive, ride a bicycle or use any tools or machines if you are affected by these symptoms.

Rivaroxaban Accord contains lactose and sodium

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.

3. How to take Rivaroxaban Accord

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

  • To prevent blood clots in the veins after a hip or knee replacement operation

    The recommended dose is one tablet Rivaroxaban Accord 10 mg once a day.

  • To treat blood clots in the veins of your legs and blood clots in the blood vessels of your lungs, and for preventing blood clots from re-occurring

After at least 6 months blood clot treatment, the recommended dose is either one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed you Rivaroxaban Accord 10 mg once a day.

Swallow the tablet preferably with water.

Take Rivaroxaban Accord can be taken with or without food.

If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take Rivaroxaban Accord. The tablet may be crushed and mixed with water or apple puree immediately before you take it. If necessary, your doctor may also give you the crushed Rivaroxaban Accord tablet through a stomach tube.

In case of enteral feeding, your doctor may crush and suspend rivaroxaban tablets in 50 mL of water and administer via a nasogastric tube or gastric feeding tube. After the administration of a crushed rivaroxaban 15 mg or 20 tablet, enteral feeding is immediately followed. Package leaflet: Information for the user Rivaroxaban Accord 10 mg film-coated tablets

rivaroxaban

Front Side

Patient Alert Card

Rivaroxaban Accord 2.5 mg

Rivaroxaban Accord 10 mg

Rivaroxaban Accord 15 mg

Rivaroxaban Accord 20 mg

♦ Keep this card with you at all times

♦ Present this card to every physician or dentist prior to treatment

I am under anticoagulation treatment with Rivaroxaban Accord (rivaroxaban)

Address:

Birth date:

Weight:

Other medicines / conditions:

In case of emergency, please notify:

Doctor’s name:

Doctor’s phone:

Doctor’s stamp:

Please also notify:

Phone:

Relationship:

Information for health care providers:

♦ INR values should not be used as they are not a dependable measure of the anticoagulant activity of Rivaroxaban Accord.

What should I know about Rivaroxaban Accord?

♦ Rivaroxaban Accord thins the blood, which prevents you from getting dangerous blood clots. ♦ Rivaroxaban Accord must be taken exactly as prescribed by your doctor. To ensure optimal protection from blood clots, never skip a dose. ♦ You must not stop taking Rivaroxaban Accord without first talking to your doctor as your risk of blood clots may increase.

♦ Tell your health care provider about any other medicines you are currently taking, took recently or intend to start taking, before you start Rivaroxaban Accord.

♦ Tell your health care provider that you are taking Rivaroxaban Accord before any surgery or invasive procedure.

When should I seek advice from my health care provider?

When taking a blood thinner such as Rivaroxaban Accord it is important to be aware of its possible side effects.

(6031696) : Date : 05_08_2024, (R) 16~10~2024 Perforation required

-
CustomerAccord
DescriptionRivaroxaban Tab 10 mg
MarketUK
LanguageEnglish
170 x 600 mm PIL
9
Version No.11 (Page 2 of 2) (IB C.I.2.a)
Date03~10~2023 (Rivaroxaban Tab. 10mg (ACC-UK) PIL)

INP180

10 7118 1 6031696

Back Side

Crushed rivaroxaban tablets are stable in water and in apple sauce for up to 4 hours.

When to take Rivaroxaban Accord

Take the tablet every day until your doctor tells you to stop.

Try to take the tablet at the same time every day to help you to remember it. Your doctor will decide how long you must continue treatment.

To prevent blood clots in the veins after a hip or knee replacement operation:

Take the first tablet 6-10 hours after your operation. If you have had a major hip operation you will usually take the tablets for 5 weeks.

If you have had a major knee operation you will usually take the tablets for 2 weeks.

If you take more Rivaroxaban Accord than you should

Contact your doctor immediately if you have taken too many Rivaroxaban Accord tablets. Taking too much Rivaroxaban Accord increases the risk of bleeding.

If you forget to take Rivaroxaban Accord

If you have missed a dose, take it as soon as you remember. Take the next tablet on the following day and then carry on taking a tablet once a day as normal. Do not take a double dose to make up for a forgotten dose.

If you stop taking Rivaroxaban Accord

Do not stop taking Rivaroxaban Accord without talking to your doctor first, because Rivaroxaban Accord prevents the development of a serious condition.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Like other similar medicines to reduce the formation of blood clots, Rivaroxaban Accord may cause bleeding which may potentially be life threatening. Excessive bleeding may lead to a sudden drop in blood pressure (shock). In some cases the bleeding may not be obvious.

Tell your doctor immediately if you experience any of the following side effects:

  • Sign of bleeding
  • bleeding into the brain or inside the skull (symptoms can include headache, one-sided weakness, vomiting, seizures, decreased level of consciousness, and neck stiffness.

    A serious medical emergency. Seek medical attention immediately!)

  • long or excessive bleeding
  • exceptional weakness, tiredness, paleness, dizziness, headache, unexplained swelling, breathlessness, chest pain or angina pectoris Your doctor may decide to keep you under closer observation or change the treatment.
  • Signs of severe skin reactions
  • spreading intense skin rash, blisters or mucosal lesions, e.g. in the mouth or eyes (Stevens-Johnson syndrome/toxic epidermal necrolysis).
  • a drug reaction that causes rash, fever, inflammation of internal organs, blood abnormalities and systemic illness (DRESS syndrome).

The frequency of these side effects is very rare (up to 1 in 10,000 people).

  • Sign of severe allergic reactions
  • swelling of the face, lips, mouth, tongue or throat; difficulty swallowing; hives and breathing difficulties; sudden drop in blood pressure.

    The frequencies of severe allergic reactions are very rare anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and ncommon (angioedema and allergic oedema; may affect up to 1 in 100 people).

    Overall list of possible side effects

Common (may affect up to 1 in 10 people)

  • reduction in red blood cells which can make the skin pale and cause weakness or breathlessness
  • bleeding in the stomach or bowel, urogenital bleeding (including blood in the urine and heavy menstrual bleeding), nose bleed, bleeding in the gum
  • bleeding into the eye (including bleeding from the whites of the eyes)
  • bleeding into tissue or a cavity of the body (haematoma, bruising)
  • coughing up blood
  • bleeding from the skin or under the skin
  • bleeding following an operation
  • oozing of blood or fluid from surgical wound
  • swelling in the limbs
  • pain in the limbs
  • impaired function of the kidneys (may be seen in tests performed by your doctor)
  • fever
  • stomach ache, indigestion, feeling or being sick, constipation, diarrhoea
  • low blood pressure (symptoms may be feeling dizzy or fainting when standing up)
  • decreased general strength and energy (weakness, tiredness), headache, dizziness
  • rash, itchy skin
  • blood tests may show an increase in some liver enzymes

Uncommon (may affect up to 1 in 100 people)

  • bleeding into the brain or inside the skull (see above, signs of bleeding)
  • bleeding into a joint causing pain and swelling
  • thrombocytopenia (low number of platelets, which are cells that help blood to clot)
  • allergic reactions, including allergic skin reactions
  • impaired function of the liver (may be seen in tests performed by your doctor)
  • blood tests may show an increase in bilirubin, some pancreatic or liver enzymes or in the number of platelets
  • fainting
  • feeling unwell

    • faster heartbeat
    • dry mouth
    • hives

Rare (may affect up to 1 in 1,000 people)

  • bleeding into a muscle
  • cholestasis (decreased bile flow), hepatitis incl. hepatocellular injury (inflamed liver incl. liver injury)
  • yellowing of the skin and eye (jaundice)
  • localised swelling
  • collection of blood (haematoma) in the groin as a complication of the cardiac procedure where a catheter is inserted in your leg artery (pseudoaneurysm)

Very rare (may affect up to 1 in 10,000 people)

  • accumulation of eosinophils, a type of white granulocytic blood cells that cause inflammation in the lung (eosinophilic pneumonia)

Not known (frequency cannot be estimated from the available data)

  • kidney failure after a severe bleeding
  • bleeding in the kidney sometimes with presence of blood in urine leading to inability of the kidneys to work properly (anticoagulant-related nephropathy)
  • increased pressure within muscles of the legs or arms after a bleeding, which leads to pain, swelling, altered sensation, numbness or paralysis (compartment syndrome after a bleeding)

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Rivaroxaban Accord

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on each blister or bottle after “EXP”. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Crushed tablets

Crushed tablets are stable in water or apple puree for up to 4 hours.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Rivaroxaban Accord contains

  • The active substance is rivaroxaban. Each tablet contains 10 mg of rivaroxaban.
  • The other ingredients are:

Tablet core

Lactose monohydrate

Croscarmellose sodium (E468)

Sodium laurilsulfate (E487)

Hypromellose 2910 (nominal viscosity 5.1 mPa.S) (E464) Cellulose, microcrystalline (E460)

Silica, colloidal anhydrous (E551)

Magnesium stearate(E572)

Film-coating

Macrogol 4000 (E1521)

Hypromellose 2910 (nominal viscosity 5.1 mPa.S) (E464) Titanium dioxide (E171)

Iron oxide red (E172)

What Rivaroxaban Accord looks like and contents of the pack

Rivaroxaban Accord 10 mg film-coated tablets are light pink to pink coloured, round, biconvex, approximately 6.00 mm in diameter, film coated tablets debossed with “IL1” on one side and plain on other side.

Rivaroxaban Accord film-coated tablets are packed in clear PVC/Aluminium blisters available in:

  • blister of 5, 10, 14, 28, 30, 98 or 100 tablets, or
  • perforated unit dose blisters of 10 x 1 or 100 x 1 tablets.

Rivaroxaban Accord film-coated tablets are also available in HDPE bottles containing 30, 90 or 500 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Accord Healthcare Limited

Sage House, 319 Pinner Road

North Harrow, Middlesex, HA1 4HF

United Kingdom

Manufacturer

Accord Healthcare Polska Sp. z o.o.

Ul. Lutomierska 50,

95-200 Pabianice, Poland

Pharmadox Healthcare Limited

KW20A Kordin Industrial Park, Paola

PLA 3000, Malta

Laboratori Fundació DAU

C/ C, 12-14 Pol. Ind. Zona Franca,

08040 Barcelona, Spain

Accord Healthcare B.V

Winthontlaan 200, 3526KV Utrecht,

Netherland

Accord Healthcare Limited,

Sage House, 319 Pinner Road,

North Harrow Middlesex, HA1 4HF,

United Kingdom

This leaflet was last revised in 10/2024.

Bleeding is the most common side effect. Do not start taking Rivaroxaban Accord if you know you are at risk of bleeding, without first discussing this with your doctor. Tell your health care provider straight away if you have any signs or symptoms of bleeding such as the following: ♦ pain

♦ swelling or discomfort

♦ headache, dizziness or weakness

♦ unusual bruising, nosebleeds, bleeding of gums, cuts that take a long time to stop bleeding ♦ menstrual flow or vaginal bleeding that is heavier than normal

♦ blood in your urine which may be pink or brown, red or black stools

♦ coughing up blood, or vomiting blood or material that looks like coffee grounds

How do I take Rivaroxaban Accord?

♦ To ensure optimal protection, Rivaroxaban Accord

  • 2.5 mg can be taken with or without food
  • 10 mg can be taken with or without food
  • 15 mg must be taken with food
  • 20 mg must be taken with food

    V1

(6031696) : Date : 05_08_2024, (R) 16~10~2024 Perforation required

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 20075/1443

Last revision stated in the text: October 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Rivaroxaban Accord 10 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Rivaroxaban
Strength 10 mg
Pharmaceutical form Oral tablet
Light pink to pink coloured, round, biconvex, approximately 6.00 mm in diameter, film coated tablets debossed with “IL1” on one side and plain on other side.
How is it taken Oral
Excipients Lactose monohydrate, Croscarmellose sodium (E468), Sodium laurilsulfate (E487), Hypromellose 2910 (nominal viscosity 5.1 mPa.S) (E464) Cellulose, microcrystalline (E460), Silica, colloidal anhydrous (E551), Magnesium stearate (E572), Macrogol 4000 (E1521), Hypromellose 2910 (nominal viscosity 5.1 mPa.S) (E464) Titanium dioxide (E171), Iron oxide red (E172)
Pack sizes 10 tablet, 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years.
Crushed tablets
Crushed rivaroxaban tablets are stable in water and in apple puree for up to 4 hours.
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antithrombotic agents, direct factor Xa inhibitors
  1. B Blood and blood forming organ drugs
    1. B01 Antithrombotic agents
      1. B01A Antithrombotic agents
        1. B01AF Direct factor Xa inhibitors
          1. B01AF01 rivaroxaban
Marketing authorisation PLGB 20075/1443 (first authorised 1 January 2021)
Marketing authorisation holder Accord Healthcare Limited
Codes GTIN 5055565774373, 5055565788059 · BNF 02080200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.